Xponential Fitness Signs Master Franchise Agreement in Japan for StretchLab
IRVINE, Calif. Xponential Fitness, Inc. (NYSE: XPOF) announced today it has signed a Master Franchise Agreement in Japan for StretchLab, the world’s largest assisted stretching brand. The agreement...
View ArticleClinical Study Result of Orelabrutinib in Patients with R/R MCL Published by...
BEIJING Blood Advances, part of leading hematology journal Blood, also a Journal of the American Society of Hematology, recently published the clinical study result of BTK (Bruton Tyrosine Kinase)...
View ArticleEdiGene to Unveil Promising Preclinical POC Data for LEAPER™ 2.0-based in...
BEIJING EdiGene, Inc., a clinical-stage biotechnology company focused on developing transformative gene-editing therapies, announced an oral presentation on the preclinical proof-of-concept (POC)...
View ArticlePharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft...
BURLINGTON, Mass. PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven...
View ArticleBeiGene Reports First Quarter 2023 Financial Results and Corporate Developments
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today reported financial results for the first quarter...
View ArticleBionik Laboratories Enters into Distribution Agreement with Pro-Med...
BOSTON Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges,...
View ArticleiTrack™ Canaloplasty to be Featured in Numerous Scientific Presentations at...
FREMONT, Calif. Nova Eye Medical Limited, a medical technology company committed to advanced ophthalmic treatment technologies and devices, is pleased to announce that its proprietary iTrack™...
View ArticleKenvue将在纽约证券交易所上市
新泽西州斯奇尔曼 (美国商业资讯)–全球营收规模最大的单一业务消费者健康公司Kenvue公司(纽约证券交易所代码:KVUE)(以下简称“Kenvue”)将于今日在纽约证券交易所上市交易,股票代码为“KVUE”,这是公司首次公开募股(以下简称“IPO”)。首席执行官(以下简称“CEO”)兼董事Thibaut Mongon以及Kenvue领导团队将通过敲响开市钟来庆祝这一时刻。...
View ArticleCANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene...
BURLINGTON, Mass. & BEIJING CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and...
View ArticleHenry Schein Acquires Regional Health Care Group, a Medical Distributor...
MELVILLE, N.Y. Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care products and services to office-based dental and medical practitioners, announced today the acquisition...
View Article剑桥大学医院通过Masimo W1™扩大虚拟护理计划
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布,英国剑桥大学医院NHS信托基金正在采用先进的健康跟踪手表Masimo W1™用于远程医疗和远程医学计划。Masimo W1可提供准确、连续的关键生理参数测量。作为一款在英国上市的医疗设备,它可与 Masimo SafetyNet®远程患者管理平台集成。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View Articleケンブリッジ大学病院、Masimo W1™によるバーチャルケア・プログラムを拡大
スイス、ノイシャテル (ビジネスワイヤ) — マシモ (NASDAQ:MASI)は本日、英国ケンブリッジ大学病院NHS財団トラストに採用されたことを発表しました。Masimo W1™は、同社のテレヘルスおよび遠隔医療プログラムで使用される高度な健康追跡用ウォッチです。主要な生理学的パラメーターの正確な連続測定を行うMasimo W1は、英国では、統合医療機器として Masimo...
View ArticleZion Pharma Announces Global Agreement with Roche to Develop and...
HONG KONG & SUZHOU, China & SHANGHAI Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, today announced that Roche has acquired...
View ArticleNeuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at...
NANJING, China On April 22, Neuboron Medical Group (NMG), a leading global Accelerator-based Boron Neutron Capture Therapy (AB-BNCT) total solution provider, and Xiamen Humanity Hospital (XHH)...
View ArticleNew Headspace Research Finds Productivity Pressure Is Driving Dread at Work
SANTA MONICA, Calif. Headspace, the provider of the world’s most accessible, comprehensive mental health platform, today released its Fifth Annual Workforce Attitudes Toward Mental Health Report...
View Articleザイオン製薬、血液脳関門浸透HER2経口チロシンキナーゼ阻害薬の開発・市販化でロシュとグローバル契約を締結
香港・蘇州、中国・上海 (ビジネスワイヤ)– 脳浸透性化合物の開発を専門とする中国のバイオ技術企業ザイオン製薬(Zion Pharma)は本日、世界有数のバイオ技術企業ロッシュが同社の主要プログラム「ZN-A-1041」の世界的権利を取得したと発表しました。同プログラムは「HER2」の略称で知られるHuman Epidermal Growth Factor Receptor...
View ArticleSINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
HONG KONG Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it will provide its inactivated COVID-19...
View Article